MedTrace Logo

The Impact of Pediatric Skin Disorders: The "Big" Study

NCT03544866 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1666

Last updated 2022-04-06

No results posted yet for this study

Summary

This study leverages the availability of a validated series of instruments to measure the effect of highly visible, chronic skin disorders, including atopic dermatitis (AD), on patients 8 years of age and above in causing stigma and psychiatric issues, particularly anxiety and depression.

Conditions

  • Chronic Pediatric Skin Conditions

Sponsors & Collaborators

Principal Investigators

  • Amy Paller · Northwestern University

Eligibility

Min Age
8 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-16
Primary Completion
2021-05-31
Completion
2022-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03544866 on ClinicalTrials.gov